抑制RNA调节因子HuR通过有效抑制损伤后神经炎症减轻脊髓损伤

IF 4.2 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Mohammed Amir Husain, Reed Smith, Robert E. Sorge, Abdulraheem Kaimari, Ying Si, Ali Z. Hassan, Abhishek Guha, Katherine A. Smith, Christopher P. Cardozo, Jennifer J. DeBerry, Shaida A. Andrabi, L. Burt Nabors, Natalia Filippova, Caroline K. Webb, Peter H. King
{"title":"抑制RNA调节因子HuR通过有效抑制损伤后神经炎症减轻脊髓损伤","authors":"Mohammed Amir Husain,&nbsp;Reed Smith,&nbsp;Robert E. Sorge,&nbsp;Abdulraheem Kaimari,&nbsp;Ying Si,&nbsp;Ali Z. Hassan,&nbsp;Abhishek Guha,&nbsp;Katherine A. Smith,&nbsp;Christopher P. Cardozo,&nbsp;Jennifer J. DeBerry,&nbsp;Shaida A. Andrabi,&nbsp;L. Burt Nabors,&nbsp;Natalia Filippova,&nbsp;Caroline K. Webb,&nbsp;Peter H. King","doi":"10.1096/fj.202500236R","DOIUrl":null,"url":null,"abstract":"<p>Neuroinflammation is a major driver of secondary tissue damage after spinal cord injury (SCI). Within minutes after SCI, activated microglia and astrocytes produce proinflammatory mediators such as TNF-α, IL-6, iNOS, and COX-2 which induce tissue injury through cytotoxicity, vascular hyperpermeability, and secondary ischemia. The inflammatory cascade is amplified by chemokines like CCL2 and CXCL1 which recruit immune cells to the injured site. HuR is an RNA regulator that promotes glial expression of many proinflammatory factors by binding to adenylate- and uridylate-rich elements in the 3' untranslated regions of their mRNAs. SRI-42127 is a small molecule which blocks HuR function by preventing its nucleocytoplasmic translocation. This study aimed to evaluate the potential of SRI-42127 to suppress neuroinflammation after SCI and improve functional outcome. Adult female mice underwent a T10 contusion injury and received SRI-42127 1 h post injury for up to 5 days. Locomotor function was assessed by open field testing, balance beam, and rotarod. Immunohistochemistry was used to assess lesion size, neuronal loss, myelin sparing, microglial/astroglial activation, and HuR localization. Inflammatory mediator expression was assessed by qPCR, immunohistochemistry, ELISA, or western blot. We found that SRI-42127 treatment significantly attenuated loss of locomotor function and post-SCI pain. There was a reduction in lesion size and neuronal loss with an increase in myelin sparing. Microglia and astrocytes showed reduced activation and reduced nucleocytoplasmic translocation of HuR. There was a striking suppression of proinflammatory mediators at the epicenter along with peripheral suppression of inflammatory responses in serum, liver, and spleen. In conclusion, HuR inhibition with SRI-42127 may be a viable therapeutic approach for suppressing neuroinflammatory responses after SCI and improving functional outcome.</p>","PeriodicalId":50455,"journal":{"name":"The FASEB Journal","volume":"39 9","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fj.202500236R","citationCount":"0","resultStr":"{\"title\":\"Inhibition of the RNA Regulator HuR Mitigates Spinal Cord Injury by Potently Suppressing Post-Injury Neuroinflammation\",\"authors\":\"Mohammed Amir Husain,&nbsp;Reed Smith,&nbsp;Robert E. Sorge,&nbsp;Abdulraheem Kaimari,&nbsp;Ying Si,&nbsp;Ali Z. Hassan,&nbsp;Abhishek Guha,&nbsp;Katherine A. Smith,&nbsp;Christopher P. Cardozo,&nbsp;Jennifer J. DeBerry,&nbsp;Shaida A. Andrabi,&nbsp;L. Burt Nabors,&nbsp;Natalia Filippova,&nbsp;Caroline K. Webb,&nbsp;Peter H. King\",\"doi\":\"10.1096/fj.202500236R\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Neuroinflammation is a major driver of secondary tissue damage after spinal cord injury (SCI). Within minutes after SCI, activated microglia and astrocytes produce proinflammatory mediators such as TNF-α, IL-6, iNOS, and COX-2 which induce tissue injury through cytotoxicity, vascular hyperpermeability, and secondary ischemia. The inflammatory cascade is amplified by chemokines like CCL2 and CXCL1 which recruit immune cells to the injured site. HuR is an RNA regulator that promotes glial expression of many proinflammatory factors by binding to adenylate- and uridylate-rich elements in the 3' untranslated regions of their mRNAs. SRI-42127 is a small molecule which blocks HuR function by preventing its nucleocytoplasmic translocation. This study aimed to evaluate the potential of SRI-42127 to suppress neuroinflammation after SCI and improve functional outcome. Adult female mice underwent a T10 contusion injury and received SRI-42127 1 h post injury for up to 5 days. Locomotor function was assessed by open field testing, balance beam, and rotarod. Immunohistochemistry was used to assess lesion size, neuronal loss, myelin sparing, microglial/astroglial activation, and HuR localization. Inflammatory mediator expression was assessed by qPCR, immunohistochemistry, ELISA, or western blot. We found that SRI-42127 treatment significantly attenuated loss of locomotor function and post-SCI pain. There was a reduction in lesion size and neuronal loss with an increase in myelin sparing. Microglia and astrocytes showed reduced activation and reduced nucleocytoplasmic translocation of HuR. There was a striking suppression of proinflammatory mediators at the epicenter along with peripheral suppression of inflammatory responses in serum, liver, and spleen. In conclusion, HuR inhibition with SRI-42127 may be a viable therapeutic approach for suppressing neuroinflammatory responses after SCI and improving functional outcome.</p>\",\"PeriodicalId\":50455,\"journal\":{\"name\":\"The FASEB Journal\",\"volume\":\"39 9\",\"pages\":\"\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-05-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fj.202500236R\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The FASEB Journal\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1096/fj.202500236R\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The FASEB Journal","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1096/fj.202500236R","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

神经炎症是脊髓损伤(SCI)后继发性组织损伤的主要驱动因素。脊髓损伤后几分钟内,活化的小胶质细胞和星形胶质细胞产生促炎介质,如TNF-α、IL-6、iNOS和COX-2,通过细胞毒性、血管高通透性和继发性缺血诱导组织损伤。像CCL2和CXCL1这样的趋化因子会将免疫细胞招募到受伤部位,从而放大炎症级联反应。HuR是一种RNA调节剂,通过结合mrna 3'非翻译区富含腺苷酸和尿苷酸的元素,促进许多促炎因子的胶质表达。SRI-42127是一种通过阻止HuR核胞质易位来阻断其功能的小分子。本研究旨在评估SRI-42127抑制脊髓损伤后神经炎症和改善功能预后的潜力。成年雌性小鼠在T10挫伤后1小时注射SRI-42127,持续5天。运动功能通过野外测试、平衡木和旋转杆进行评估。免疫组织化学用于评估病变大小、神经元丢失、髓磷脂保留、小胶质细胞/星形胶质细胞激活和HuR定位。通过qPCR、免疫组织化学、ELISA或western blot检测炎症介质的表达。我们发现SRI-42127治疗可显著减轻运动功能丧失和脊髓损伤后疼痛。病变大小和神经元损失减少,髓磷脂保留增加。小胶质细胞和星形胶质细胞显示HuR的激活减少和核质易位减少。在震中有显著的促炎介质的抑制,以及外周血中血清、肝脏和脾脏的炎症反应的抑制。总之,用SRI-42127抑制HuR可能是抑制脊髓损伤后神经炎症反应和改善功能预后的可行治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Inhibition of the RNA Regulator HuR Mitigates Spinal Cord Injury by Potently Suppressing Post-Injury Neuroinflammation

Inhibition of the RNA Regulator HuR Mitigates Spinal Cord Injury by Potently Suppressing Post-Injury Neuroinflammation

Neuroinflammation is a major driver of secondary tissue damage after spinal cord injury (SCI). Within minutes after SCI, activated microglia and astrocytes produce proinflammatory mediators such as TNF-α, IL-6, iNOS, and COX-2 which induce tissue injury through cytotoxicity, vascular hyperpermeability, and secondary ischemia. The inflammatory cascade is amplified by chemokines like CCL2 and CXCL1 which recruit immune cells to the injured site. HuR is an RNA regulator that promotes glial expression of many proinflammatory factors by binding to adenylate- and uridylate-rich elements in the 3' untranslated regions of their mRNAs. SRI-42127 is a small molecule which blocks HuR function by preventing its nucleocytoplasmic translocation. This study aimed to evaluate the potential of SRI-42127 to suppress neuroinflammation after SCI and improve functional outcome. Adult female mice underwent a T10 contusion injury and received SRI-42127 1 h post injury for up to 5 days. Locomotor function was assessed by open field testing, balance beam, and rotarod. Immunohistochemistry was used to assess lesion size, neuronal loss, myelin sparing, microglial/astroglial activation, and HuR localization. Inflammatory mediator expression was assessed by qPCR, immunohistochemistry, ELISA, or western blot. We found that SRI-42127 treatment significantly attenuated loss of locomotor function and post-SCI pain. There was a reduction in lesion size and neuronal loss with an increase in myelin sparing. Microglia and astrocytes showed reduced activation and reduced nucleocytoplasmic translocation of HuR. There was a striking suppression of proinflammatory mediators at the epicenter along with peripheral suppression of inflammatory responses in serum, liver, and spleen. In conclusion, HuR inhibition with SRI-42127 may be a viable therapeutic approach for suppressing neuroinflammatory responses after SCI and improving functional outcome.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
The FASEB Journal
The FASEB Journal 生物-生化与分子生物学
CiteScore
9.20
自引率
2.10%
发文量
6243
审稿时长
3 months
期刊介绍: The FASEB Journal publishes international, transdisciplinary research covering all fields of biology at every level of organization: atomic, molecular, cell, tissue, organ, organismic and population. While the journal strives to include research that cuts across the biological sciences, it also considers submissions that lie within one field, but may have implications for other fields as well. The journal seeks to publish basic and translational research, but also welcomes reports of pre-clinical and early clinical research. In addition to research, review, and hypothesis submissions, The FASEB Journal also seeks perspectives, commentaries, book reviews, and similar content related to the life sciences in its Up Front section.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信